GO:0051729 germline cell cycle switching, mitotic to meiotic cell cycle: Mechanism, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0051729 describes the developmental switch in germline cells from mitotic proliferation to meiotic division, a process essential for producing haploid gametes.
The transition is controlled by conserved regulators including cyclin E/Cdk2, GLD-1, METT-10, TRD-1, Geminin, and β-importin Tnpo-SR.
Transcriptomic and genetic studies in Drosophila and C. elegans have identified key meiotic entry genes and their temporal expression patterns.
Disruption of this switch causes spermatogenesis defects, infertility, and germ cell tumors, highlighting its clinical relevance.
CRISPR-based knockout, knock-in, and overexpression models enable precise functional interrogation of genes controlling meiotic entry.
Understanding GO:0051729 informs reproductive biology, cancer research, and the development of gene-editing therapies for germline disorders.

Description

The transition from mitotic proliferation to meiotic division in germline cells is a fundamental developmental decision that ensures the production of haploid gametes. This process, annotated as GO:0051729 (germline cell cycle switching, mitotic to meiotic cell cycle), involves coordinated changes in cell cycle machinery, gene expression, and cellular morphology. In organisms such as Drosophila melanogaster and Caenorhabditis elegans, germline stem cells initially divide mitotically to expand the germ cell pool before entering a pre-meiotic S phase and subsequent meiotic prophase. Defects in this switch can lead to infertility, germ cell tumors, and developmental abnormalities, making it a critical area of reproductive and cancer research. Research over the past two decades has identified conserved molecular regulators that govern this transition. For example, cyclin E and Cdk2 control the mitosis/meiosis decision in C. elegans by modulating GLD-1 activity. METT-10, a putative methyltransferase, inhibits germ cell proliferative fate, thereby promoting meiotic entry. In Drosophila, β-importin Tnpo-SR is required for germline stem cell maintenance and oocyte differentiation, linking nuclear transport to the meiotic switch. Transcriptomic analyses have further revealed dynamic expression of meiotic genes during the mitosis-to-meiosis transition in Drosophila females. Understanding GO:0051729 is essential for dissecting the genetic and molecular basis of gametogenesis, as well as for developing therapeutic strategies for infertility and germ cell malignancies. This article synthesizes authoritative QuickGO annotations and verified PubMed literature to provide a research-grade overview of the mechanisms, key genes, and experimental models relevant to this process.

germline cell cycle switching, mitotic to meiotic cell cycle At A Glance

GO ID GO:0051729
GO term germline cell cycle switching, mitotic to meiotic cell cycle
Ontology biological_process
Synonym germline entry into meiosis; germline meiotic entry; germline conversion to meiosis; germline initiation of meiotic cell cycle
Major function Switching germline cells from mitotic proliferation to meiotic division to produce haploid gametes
Key regulators Cyclin E/Cdk2, GLD-1, METT-10, TRD-1, Geminin, β-importin Tnpo-SR
Model organisms Drosophila melanogaster, Caenorhabditis elegans, Mus musculus
Associated diseases Infertility, spermatogenesis defects, germ cell tumors

What Is GO:0051729?

GO:0051729, germline cell cycle switching, mitotic to meiotic cell cycle, is defined as the process in which a germline cell switches cell cycle mode from mitotic to meiotic division. This biological process encompasses the regulatory and cellular events that commit a germline cell to enter meiosis, including the cessation of mitotic divisions, pre-meiotic DNA replication, and the initiation of meiotic prophase. It is a critical developmental decision that ensures the production of haploid gametes and is conserved across sexually reproducing organisms.

Why Is germline cell cycle switching, mitotic to meiotic cell cycle Important in Cell Biology?

GO:0051729 is fundamental to sexual reproduction because it governs the irreversible commitment of germline cells to meiosis, a specialized cell division that generates haploid gametes. Errors in this switch can cause infertility, abnormal germ cell proliferation, and tumorigenesis. Studying this process provides insights into conserved cell cycle control mechanisms and offers potential targets for reproductive medicine and cancer therapy.
Ensures production of haploid gametes for sexual reproduction.
Prevents germ cell tumors by terminating mitotic proliferation.
Infertility and spermatogenesis defects result from disrupted meiotic entry.
Conserved regulators like cyclin E/Cdk2 and GLD-1 provide mechanistic insights.
β-importin Tnpo-SR links nuclear transport to germline differentiation.
Transcriptomic studies reveal dynamic gene expression during the transition.
CRISPR screens can identify novel meiotic entry genes.
The switch is a model for understanding cell fate decisions.
Dysregulation is implicated in germ cell malignancies.
Understanding this process aids development of gene-editing therapies for germline disorders.

What Happens During germline cell cycle switching, mitotic to meiotic cell cycle?

Cessation of Mitotic Proliferation
In simple terms: Germ cells stop dividing by mitosis and prepare for meiosis.
The first step in the mitotic-to-meiotic switch is the exit from the mitotic cell cycle. In C. elegans, cyclin E and Cdk2 promote mitotic proliferation; their downregulation is required for meiotic entry. METT-10 acts to inhibit germ cell proliferative fate, thereby allowing cells to exit mitosis. In Drosophila, β-importin Tnpo-SR is necessary for germline stem cell maintenance, and its depletion leads to premature differentiation. This phase involves changes in cell cycle regulators and checkpoint controls.
Pre-meiotic DNA Replication
In simple terms: The cell copies its DNA one last time before meiosis.
Before entering meiosis, germline cells undergo a final round of DNA replication. Geminin, an inhibitor of DNA replication licensing, is critical at this stage; its deletion in pre-meiotic DNA replication causes spermatogenesis defects and infertility in mice. This step ensures that each chromosome is duplicated once, setting the stage for two meiotic divisions.
Initiation of Meiotic Prophase
In simple terms: The cell begins the specialized divisions that produce gametes.
Following pre-meiotic S phase, germline cells enter meiotic prophase, characterized by synapsis, recombination, and formation of the synaptonemal complex. Transcriptomic analysis in Drosophila females has identified a suite of meiotic genes that are upregulated during this transition. Regulators of alternative polyadenylation also operate at the mitosis-to-meiosis transition, influencing transcript stability and translation.
Regulation by RNA-Binding Proteins
In simple terms: Proteins that bind RNA control when meiosis starts.
RNA-binding proteins such as GLD-1 play a central role in the mitosis/meiosis decision in C. elegans. Cyclin E and Cdk2 control GLD-1 activity, and loss of GLD-1 leads to excessive mitotic proliferation and failure to enter meiosis. TRD-1, a TPR-containing protein, also regulates cell fate choice in the developing germ line. These factors coordinate post-transcriptional control of meiotic entry genes.
Nuclear Transport and Cellular Morphogenesis
In simple terms: Transport into the nucleus and cell shape changes help the switch.
Nuclear transport factors such as β-importin Tnpo-SR are required for germline stem cell maintenance and oocyte differentiation in Drosophila. Coordinated changes in cell polarity and proliferation are essential for proper meiotic entry, as reviewed by Hinnant et al.. These processes ensure that germ cells are positioned and structured correctly for meiosis.

Key Genes Involved in GO:0051729 germline cell cycle switching, mitotic to meiotic cell cycle

The following genes and proteins have been experimentally implicated in the regulation of GO:0051729 across model organisms.
GeneMajor RoleResearch Relevance
Cyclin E (Drosophila/C. elegans)Promotes mitotic proliferation; downregulation required for meiotic entryKey regulator of the mitosis/meiosis decision
Cdk2Partners with Cyclin E to control GLD-1 and meiotic entryTarget for cell cycle manipulation
GLD-1RNA-binding protein that promotes meiosis and inhibits mitosisCentral switch factor in C. elegans
METT-10Putative methyltransferase that inhibits germ cell proliferative fatePromotes meiotic entry
TRD-1TPR-containing protein regulating germ line cell fateInvolved in cell fate choice
GemininInhibits DNA replication licensing; required for pre-meiotic S phaseDeletion causes spermatogenesis defects
Tnpo-SR (β-importin)Nuclear transport factor for germline stem cell maintenance and oocyte differentiationLinks transport to meiotic entry
Meiotic genes (e.g., spo-11, rad-51)Execute recombination and synapsis during meiotic prophaseTranscriptomically upregulated at transition
Alternative polyadenylation factorsRegulate transcript stability at mitosis-to-meiosis transitionControl gene expression timing
Notch signaling componentsRegulate germline stem cell self-renewal and differentiationContext-dependent role in meiotic entry
BMP signaling componentsControl germline stem cell maintenanceInfluence the switch
piRNA pathway componentsSilence transposons and regulate germline gene expressionIndirectly affect meiotic entry
Insulin/IGF signaling componentsModulate germline stem cell proliferationNutrient-dependent regulation
Histone modifiersEpigenetic regulation of meiotic genesPotential regulators
Transcription factors (e.g., FBF-1/2)Repress meiotic genes in mitotic germ cellsControl timing of meiosis
Cytoplasmic polyadenylation element binding proteinsRegulate translation of meiotic transcriptsPost-transcriptional control
Cell polarity proteins (e.g., PAR complex)Establish asymmetric divisions in germline stem cellsInfluence differentiation
Checkpoint kinases (e.g., ATR, ATM)Monitor DNA replication and recombinationEnsure genomic integrity during meiosis

How Is germline cell cycle switching, mitotic to meiotic cell cycle Regulated?

The mitosis-to-meiosis switch is regulated at multiple levels, including transcriptional, post-transcriptional, and post-translational control. Cyclin E/Cdk2 activity modulates GLD-1, which in turn represses mitotic genes and promotes meiotic entry. METT-10 inhibits proliferative fate, likely through methylation of target proteins. RNA-binding proteins such as TRD-1 and alternative polyadenylation factors control transcript stability and translation. Nuclear transport via Tnpo-SR ensures proper localization of key regulators. Additionally, signaling pathways such as Notch, BMP, and insulin/IGF modulate germline stem cell behavior and the timing of differentiation.

germline cell cycle switching, mitotic to meiotic cell cycle and Human Disease

GeneDisease / BiologyPotential Experimental Model
GemininSpermatogenesis defect and infertilityKnockout mouse, spermatocyte-specific deletion
METT-10Germ cell tumor susceptibilityC. elegans knockout, human cell line knockdown
Cyclin E / Cdk2Infertility, germ cell tumorsConditional knockout in mouse germline
GLD-1Defective meiotic entry, germline tumorsC. elegans mutant, human homolog (QKI) models
Tnpo-SRPremature germline differentiation, infertilityDrosophila knockout, human TNPO1/2 knockdown
Infertility and Spermatogenesis Defects
Disruption of the mitotic-to-meiotic switch can cause infertility. Geminin deletion in the pre-meiotic DNA replication stage leads to spermatogenesis defects and infertility in mice. Similarly, mutations affecting meiotic entry genes in humans may result in azoospermia or premature ovarian failure. Understanding the molecular players in GO:0051729 provides candidate targets for diagnostic and therapeutic interventions.
Germ Cell Tumors
Failure to exit the mitotic cycle and enter meiosis can lead to uncontrolled germ cell proliferation and tumor formation. METT-10, which inhibits proliferative fate, is a tumor suppressor-like factor in C. elegans. In humans, dysregulation of meiotic entry pathways is implicated in germ cell tumors such as seminomas and dysgerminomas. Research into GO:0051729 may reveal new biomarkers or therapeutic targets.
Reproductive Aging
The efficiency of meiotic entry declines with age, contributing to reduced fertility. Studies in Drosophila and C. elegans have shown that regulators such as β-importin Tnpo-SR and cyclin E/Cdk2 influence germline stem cell maintenance and differentiation. These findings suggest that age-related fertility decline may involve altered expression or activity of meiotic switch genes.

From germline cell cycle switching, mitotic to meiotic cell cycle-Related Genes to Experimental Models

Research QuestionSuitable Model
Does gene X regulate meiotic entry?CRISPR knockout in C. elegans or Drosophila germline
What is the effect of a point mutation in a meiotic switch gene?CRISPR point mutation knock-in in mouse germline stem cells
How does a tagged protein localize during the switch?Knock-in of fluorescent tag (e.g., GFP) in Drosophila or mouse
Can overexpression of gene Y drive premature meiosis?Transgenic overexpression in germline
What are the transcriptomic changes during the switch?RNA-seq of sorted germ cells at different stages
Which genes are essential for fertility?Genome-wide CRISPR library screening in germline cell lines

How to Study the germline cell cycle switching, mitotic to meiotic cell cycle Process

MethodWhat It MeasuresTypical Application
RNA-seqGlobal transcript levelsIdentify meiotic genes upregulated at transition
Single-cell RNA-seqTranscriptomes of individual germ cellsResolve heterogeneity in meiotic entry
CRISPR knockout screeningGene essentiality for meiotic entryDiscover novel regulators
ChIP-seqProtein-DNA interactionsMap transcription factor binding at meiotic genes
Proteomics (LC-MS/MS)Protein abundance and modificationsDetect METT-10 substrates
Live-cell imagingDynamic localization and cell divisionsTrack germline stem cell differentiation
Ribo-seqTranslational efficiencyAssess post-transcriptional control
3' end sequencingAlternative polyadenylation isoformsStudy transcript stability at transition
Transcriptomic Profiling
RNA-seq and single-cell RNA-seq can capture dynamic gene expression changes during the mitosis-to-meiosis transition. Vallés et al. used transcriptomic analysis to identify meiotic genes upregulated during this switch in Drosophila females. Alternative polyadenylation events can be detected using 3' end sequencing.
Genetic Screens and CRISPR Libraries
Forward and reverse genetic screens in model organisms have identified key regulators such as METT-10, TRD-1, and GLD-1. CRISPR-based library screening enables systematic knockout of candidate genes to assess their role in meiotic entry.
Imaging and Live-Cell Tracking
Fluorescent reporters and live imaging allow visualization of germline stem cell divisions and meiotic entry in real time. Tagged knock-in of proteins like Tnpo-SR can reveal their subcellular localization. Time-lapse microscopy in C. elegans has been used to track the mitosis-to-meiosis decision.
Proteomics and Post-Translational Modification Analysis
Mass spectrometry-based proteomics can identify protein interactions and modifications (e.g., methylation by METT-10) that regulate the switch. Phosphoproteomics may reveal signaling changes downstream of cyclin E/Cdk2.

How CRISPR Can Be Used to Study GO:0051729 germline cell cycle switching, mitotic to meiotic cell cycle

Knockout

CRISPR knockout of candidate genes in germline cells or model organisms can reveal their requirement for the mitotic-to-meiotic switch. For example, knockout of METT-10 in C. elegans leads to excessive proliferative fate, while knockout of Geminin in mice causes spermatogenesis defects. High-throughput knockout screens can identify novel meiotic entry regulators.

Point Mutation

Introducing precise point mutations via CRISPR base editing or homology-directed repair allows structure-function analysis of key regulators. For instance, mutating phosphorylation sites in GLD-1 or cyclin E can test their role in the switch. Point mutations in Geminin can dissect its licensing inhibitory function.

Knock-in

Knock-in of fluorescent tags (e.g., GFP, mCherry) or epitope tags enables visualization and biochemical purification of proteins involved in meiotic entry. Tagging Tnpo-SR in Drosophila has been used to study its localization. Knock-in of loxP sites allows conditional alleles for stage-specific deletion.

Overexpression

CRISPR activation (CRISPRa) or transgenic overexpression can test whether a gene is sufficient to drive meiotic entry. Overexpression of cyclin E or Cdk2 in C. elegans germline affects the mitosis/meiosis decision. Overexpression of METT-10 may enhance meiotic entry.

How EDITGENE Supports germline cell cycle switching, mitotic to meiotic cell cycle Research

Researchers studying germline cell cycle switching, mitotic to meiotic cell cycle-related genes often need to determine whether a candidate gene is causally involved in meiotic entry, how mutations affect fertility, and what therapeutic potential they hold. EDITGENE provides end-to-end CRISPR services to accelerate these discoveries.
Contact EDITGENE today to design your custom CRISPR model for germline cell cycle switching, mitotic to meiotic cell cycle research.

Frequently Asked Questions About germline cell cycle switching, mitotic to meiotic cell cycle

GO:0051729 is the Gene Ontology term for the biological process in which a germline cell switches from mitotic to meiotic cell cycle, a key step in gamete production.
Key genes include cyclin E, Cdk2, GLD-1, METT-10, TRD-1, Geminin, and Tnpo-SR, as identified in C. elegans, Drosophila, and mouse studies.
It is regulated by cyclin E/Cdk2 signaling, RNA-binding proteins like GLD-1, methylation by METT-10, and nuclear transport factors such as Tnpo-SR.
Proper meiotic entry ensures the production of haploid gametes; defects lead to infertility and spermatogenesis failure.
Infertility, spermatogenesis defects, and germ cell tumors are linked to disrupted meiotic entry.
Drosophila melanogaster and Caenorhabditis elegans are widely used due to their genetic tractability and conserved meiotic pathways.
CRISPR knockout, point mutation, knock-in, and overexpression enable functional dissection of candidate genes in germline cells.
RNA-seq, single-cell RNA-seq, Ribo-seq, proteomics, and live-cell imaging are commonly employed.
Geminin inhibits DNA replication licensing and is required for pre-meiotic S phase; its deletion causes spermatogenesis defects.
METT-10, a putative methyltransferase, inhibits germ cell proliferative fate and promotes entry into meiosis.

Conclusion

GO:0051729, germline cell cycle switching from mitosis to meiosis, is a cornerstone of reproductive biology. Research across model organisms has elucidated conserved regulators such as cyclin E/Cdk2, GLD-1, METT-10, and Tnpo-SR that orchestrate this transition. Defects in this process lead to infertility and germ cell tumors, underscoring its clinical importance. Advances in CRISPR gene editing and high-throughput screening now enable precise functional interrogation of these pathways, promising new insights and therapeutic opportunities.

References

  1. 1. Vallés AM et al.. 2024. Transcriptomic analysis of meiotic genes during the mitosis-to-meiosis transition in Drosophila females.. Genetics 228(2) PMID: 39225982
  2. 2. Hinnant TD et al.. 2020. Coordinating Proliferation, Polarity, and Cell Fate in the Drosophila Female Germline.. Front Cell Dev Biol 8:19 PMID: 32117961
  3. 3. Beachum AN et al.. 2023. β-importin Tnpo-SR promotes germline stem cell maintenance and oocyte differentiation in female Drosophila.. Dev Biol 494:1-12 PMID: 36450333
  4. 4. Shan L et al.. 2017. Regulators of alternative polyadenylation operate at the transition from mitosis to meiosis.. J Genet Genomics 44(2):95-106 PMID: 28190776
  5. 5. Yuan Y et al.. 2017. Geminin deletion in pre-meiotic DNA replication stage causes spermatogenesis defect and infertility.. J Reprod Dev 63(5):481-488 PMID: 28690291
  6. 6. Dorsett M et al.. 2009. METT-10, a putative methyltransferase, inhibits germ cell proliferative fate in Caenorhabditis elegans.. Genetics 183(1):233-47 PMID: 19596901
  7. 7. Jeong J et al.. 2011. Cyclin E and Cdk2 control GLD-1, the mitosis/meiosis decision, and germline stem cells in Caenorhabditis elegans.. PLoS Genet 7(3):e1001348 PMID: 21455289
  8. 8. Hughes S et al.. 2014. The C. elegans TPR Containing Protein, TRD-1, Regulates Cell Fate Choice in the Developing Germ Line and Epidermis.. PLoS One 9(12):e114998 PMID: 25493563
Contact Us
*
*
*
*
How did you hear about us: